Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy adult patients (greater than 18 years) requiring ORIF of maxillofacial fractures 2.ASA physical status I or II
Exclusion criteria
Exclusion criteria: 1.Patients with allergy or contraindication to bupivacaine or dexmedetomidine. 2. Patients with severe hepatic, renal or cardiac diseases 3. Pregnant or lactating women 4. Patients with cognitive impairment affecting pain reporting 5. Patients with coagulopathy and bleeding disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the time to first rescue analgesia during postoperative period between patients receiving bupivacaine combined with dexmedetomidine versus bupivacaine alone regional nerve blocks in Open Reduction and Internal Fixation for maxillofacial trauma.Timepoint: The time to first rescue analgesia (IV Paracetamol 1g) in the post operative period will be recorded in mins and calculated from the time of placement of incision. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the total intraoperative opioid usage between the groupsTimepoint: Intra-operatively, after the standard anaesthesia intubation & maintenance protocol, monitoring of total Opioid & NSAID used in mcg/mg during the procedure is done.;To compare the intraoperative heart rate & blood pressure between the groupsTimepoint: Before intubation the baseline parameters of heart rate, non-invasive blood pressure (NIBP) are obtained. Following standard anaesthesia intubation protocol, Heart rate (HR), Mean Arterial Pressure (MAP) intraoperative monitoring will be done every 15 minutes till the end of the procedure.;To compare patient-reported satisfaction with pain control between the groupsTimepoint: At the time of discharge the pain control satisfaction by the patient would be obtained through a 2-point LIKERT scale.;To compare incidence of any adverse effects due to the regional nerve blocks between the groupsTimepoint: The incidence of any adverse effects due to the regional nerve blocks will be assessed from the time of administration of the nerve block till the patient is discharged. | — |
Countries
India
Contacts
Jawaharlal Institute of Postgraduate Medical Education and Research